Tue, Aug 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Estimize launches Mergerize, announces funding round

Thursday, March 27, 2014

Bailey McCann, Opalesque New York:

New York-based Estimize, a startup focused on providing crowdsourced buy-side earnings coverage is branching out. The company launched Mergerize.com which will focus on covering merger and acquisition activity in a similar fashion. The company claims that Estimize coverage of public companies is over 60% more accurate than traditional sell-side analyst coverage, a claim which has been validated by the Deutsche Bank Quantitative Research team in a recent paper. To wit:

"We found multiple benefits to using the Estimize dataset; especially in the case of short-term applications in which accuracy is essential. Another interesting byproduct of the analysis was the power of crowdsourcing. We found that some of the value-added in the Estimize dataset was due to the "wisdom of crowds" effect as more predictions give way to greater accuracy. Moreover, the diversity of the contributors provides a greater spectrum of information which can potentially improve investment strategies based on estimates. Our initial findings show that the more timely Estimize forecasts provide greater short-term accuracy when compared to IBES."

The goal now is to replicate this with corporate actions on Mergerize. "We're going to start with M&A," Estimize founder and CEO Leigh Drogen tells Op......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner